liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
The Immune Risk Phenotype and IL-6 among Nonagenarians and Associations with Morbidity and Mortality: Findings from the Swedish NONA Immune Longitudinal Study
Linköping University, Department of Clinical and Experimental Medicine, Infectious Diseases . Linköping University, Faculty of Health Sciences.
Department of Natural Science and Biomedicine, School of Health Sciences, Jönköping University, Jönköping, Sweden.
Department of Microbiology, Ryhov Hospital, Jönköping, Sweden.
Unilever Corporate Research, Colworth House, Sharnbrook.
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Abstract [en]

In this NONA immune longitudinal study, we examine 4-year mortality in relation to a set of laboratory parameters, morbidity and cause of death in a population-based sample of oldest-old individuals (n=138). Four groups were constructed based on levels for the CD4/CD8 ratio (above or below one = IRP, immune risk phenotype group) and levels for IL-6 (below or above the median 3.15 pg/mL). 4-year mortality was higher in the “IRP” group (73 %), the “IL-6” group (64 %), and the “Double risk group” (82 %) compared with the “No risk” group (29 %; p-values between .005 and .000). Cognitive dysfunction and dementia were more common in the two groups with elevated IL-6 levels (p-values between .014 and .001), whereas cardiovascular disease tended (p = .081) to be associated with both “IRP” and “IL-6” groups. The most common cause of death was related to cardio- and cerebrovascular disease (59 %,), followed by infection in 15 % of the cases and cancer in 7 %. Despite their strong associations with 4-year mortality, neither IRP nor IL-6 could be linked to any specific cause of death, possibly because both IRP and IL-6 are multi-factorial risk factors, being associated with several different diseases and mechanisms which cause death.

Keyword [en]
survival, mortality, CMV, cytomegalovirus, CD8, T-cells, inflammation, immuner risk phenotype, IRP, cause of death
National Category
Immunology in the medical area
URN: urn:nbn:se:liu:diva-54674OAI: diva2:306855
Available from: 2010-03-31 Created: 2010-03-31 Last updated: 2010-04-07
In thesis
1. The Immune System in the Oldest-Old: Clinical and Immunological Studies in the NONA Immune Cohort
Open this publication in new window or tab >>The Immune System in the Oldest-Old: Clinical and Immunological Studies in the NONA Immune Cohort
2010 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

The oldest-old (people aged 80 or older) constituted 5 % of the population in Sweden in 2000, an increase from 1.5 % fifty years earlier. The immune system undergoes dramatic changes at high age, sometimes referred to as “immunosenescence”. However, the natures of these changes, and in particular, their clinical consequences are incompletely understood. In a previous longitudinal study, a set of immune parameters were identified and termed immune risk phenotype (IRP) because of an association with increased mortality. The IRP consists of changes in the T lymphocyte compartment, in particular an inverted CD4/CD8 ratio. The IRP was found to be associated with cytomegalovirus (CMV) infection, which through expansions of cytolytic anti-viral CD8 cell responses was ascribed a role in the development of IRP. The general aim of this thesis was to increase the knowledge of changes in the immune system and their clinical consequences in the oldest-old. The population-based random sample of the longitudinal NONA-Immune Study (n = 138, mean age 90 years at baseline) was used for all investigations.

In paper I, the effects on sample size of various exclusion protocols for immune studies of the elderly was examined. The commonly used SENIEUR protocol, selecting individuals representing ‘normal ageing’, excluded 90 % of nonagenarians. Based on different protocol criteria, individuals were grouped into ‘very healthy’, ‘moderately healthy’ or ‘frail’. The prevalence of CMV was similar across the groups. Further, differentiated CD8 populations associated with CMV, i.e. those expressing CD56, CD57 and CD45RA while lacking expression of CD27 and CD28, were equally distributed across the groups of the oldest-old, but were, as expected, significantly increased in the elderly compared to a middle aged control group. The findings showed that lymphocyte subsets associated with IRP might serve as significant biomarkers of ageing independent of the overall health status, also supporting the notion that immunological studies of the oldest-old should be done in population-based non-selected populations.

The IRP and the presence of low-grade inflammation, for example increase of   IL-6 in plasma, constitute major predictors of 2-year mortality in the oldest-old. In paper II, the CD4/CD8 ratio and IL-6 were found to predict 97 % of observed survival and 57 % of deaths over 2 years. The impact of IRP and IL-6 on 2-year survival was independent of age, sex and several diseases. The longitudinal design allowed temporal evaluations, suggesting a sequence of events starting with IRP and leading to inflammation in the decline state.                                      Four-year mortality in the oldest-old (paper III) was found to be mainly related to markers of inflammation and IRP. Individuals with both inverted CD4/CD8 ratio and high IL-6 level had significantly higher 4 year mortality (82 %) compared to individuals with CD4/CD8 ratio ³ 1 and low IL-6 level (29 %) at baseline. The presence of IRP and increased IL-6 level showed some associations with presence of diseases; in particular, IL6 was associated with the presence of cognitive impairment. However, despite being strong predictors of mortality, IRP and IL-6 could not be linked to any specific cause of death, probably due to the multi-factorial nature of these factors.                                                                                                                             The prevalence of antinuclear antibodies (ANA) in the oldest-old was higher compared to younger controls (paper IV). The difference across age was most pronounced in men, showing low levels at younger age, whereas the prevalence among the oldest-old men reached a similar level as in women. There was no association between the presence of ANA and IRP, CMV status or health status in the oldest-old.

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2010. 75 p.
Linköping University Medical Dissertations, ISSN 0345-0082 ; 1172
Elderly, selection, health status, lymphocyte subsets, CD8, CMV, cytomegalovirus, immune risk, immune risk phenotype, IRP, T-cells, interleukin 6, IL-6, survival, mortality, antinuclear antibodies, ANA, ageing, immunosenescence
National Category
Medical and Health Sciences
urn:nbn:se:liu:diva-54672 (URN)978-91-7393-429-9 (ISBN)
Public defence
2010-04-23, Originalet, Qulturum, Hus B4, Länssjukhuset Ryhov, Jönköping, 13:00 (Swedish)
Available from: 2010-04-07 Created: 2010-03-31 Last updated: 2011-02-23Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Nilsson, Bengt-OlofErnerudh, Jan
By organisation
Infectious Diseases Faculty of Health SciencesClinical Immunology Department of Clinical Immunology and Transfusion Medicine
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 37 hits
ReferencesLink to record
Permanent link

Direct link